Freedom Investment Management, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2019$248,000
-47.7%
2,154
-48.8%
0.02%
-26.7%
Q3 2018$474,000
+9.2%
4,209
-13.0%
0.03%
+15.4%
Q2 2018$434,000
+9.9%
4,840
-28.8%
0.03%
+30.0%
Q4 2017$395,000
+2.9%
6,801
-20.5%
0.02%
-4.8%
Q3 2017$384,000
+25.9%
8,554
+10.9%
0.02%
+23.5%
Q2 2017$305,0007,7130.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders